EC approves expanded indication for Merck’s Pneumococcal 15-valent Conjugate Vaccine EP News Bureau Oct 27, 2022 The approval facilitates availability of Vaxneuvance for this population in all 27 European Union (EU) member states plus Iceland,…
Merck gets US FDA nod of adult pneumococcal 15-valent conjugate vaccine EP News Bureau Jul 17, 2021 VAXNEUVANCE demonstrated non-inferior immune responses for the serotypes shared with PCV13 (1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C,…
